Loading...
T790M and acquired resistance of EGFR TKI: a literature review of clinical reports
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib and erlotinib are promising therapies for patients with advanced non-small-cell lung cancer (NSCLC). Patients with somatic activating mutations in the EGFR gene have dramatic response initially, but would eve...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Pioneer Bioscience Publishing Company
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3256494/ https://ncbi.nlm.nih.gov/pubmed/22263058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2010.12.02 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|